Document Detail

The renin-angiotensin system and hypertension.
MedLine Citation:
PMID:  6754184     Owner:  NLM     Status:  MEDLINE    
1. The renin-angiotensin system because of its unique relationship to both aldosterone secretion and vascular reactivity is important in the control of blood pressure and may be useful in determining the cause of hypertension. 2. Patients with volume expanded hypertension almost invariably have low renin levels. Some of these patients have primary aldosteronism, others have excess production of nonaldosterone mineralocorticoids. The majority have essential hypertension. 3. Many patients with low renin essential hypertension have an enhanced adrenal response to angiotensin II as the underlying mechanism. 4. Fifteen to twenty per cent of patients with an elevated blood pressure have renin-dependent angiotensinogenic hypertension. Some of these patients have renal lesions to account for the elevated renin levels, for example, renal artery stenosis. However, some patients with high renin essential hypertension have a decreased adrenal response to angiotensin II as the primary mechanism for their high renin levels and potentially for their elevated blood pressure. 5. Patients who fall into this latter group may not only have alterations in angiotensin's interaction with the adrenal but also with other target tissues, for example, renal vasculature. 6. Thus, as many as 60% of patients with essential hypertension may have an alteration in the interaction of angiotensin II with its target tissues which could be the major factor underlying the pathogenesis of their elevated blood pressure.
G H Williams
Related Documents :
1873004 - Ambulatory blood pressure variation is related to plasma renin activity in borderline h...
19337534 - Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide...
17562974 - Renin gene polymorphisms and haplotypes, blood pressure, and responses to renin-angiote...
3741724 - Cardiovascular toxicity and distribution kinetics of intravenous chloroquine.
1649294 - Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic gmp phosp...
3656174 - In utero right ventricular output in the fetal lamb: the effect of heart rate.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology. Supplement     Volume:  7     ISSN:  0143-9294     ISO Abbreviation:  Clin Exp Pharmacol Physiol Suppl     Publication Date:  1982  
Date Detail:
Created Date:  1983-01-19     Completed Date:  1983-01-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7611484     Medline TA:  Clin Exp Pharmacol Physiol Suppl     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  31-40     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Glands / drug effects
Angiotensin II / physiology
Blood Vessels / drug effects
Blood Volume
Hypertension / etiology*,  physiopathology
Renin / blood
Renin-Angiotensin System*
Sodium / adverse effects
Reg. No./Substance:
11128-99-7/Angiotensin II; 7440-23-5/Sodium; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of prostacyclin and prostaglandin E2 on the secretion of pancreatic juice in the dog.
Next Document:  In vivo conversion of [des-Asp1]-angiotensin I to [des-Asp1]-angiotensin II in conscious sheep.